Cargando…

Alteration of gene expression profile in CD3(+) T-cells after downregulating MALT1

BACKGROUND: T cell immunodeficiency is a common feature in patients with different kinds of hematological disease such as T cell non-Hodgkin lymphoma (T-NHL), B cells NHL (B-NHL), NK/T cell NHL (NK/T-CL) and acute myeloid leukemia (AML). In our recent research, we found that significantly lower expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xu, Lu, Shuai, Xiao, Yankai, Xu, Ling, Zhou, Lingling, Hu, Junyan, Li, Bo, Zeng, Chengwu, Li, Yangqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251356/
https://www.ncbi.nlm.nih.gov/pubmed/30538965
http://dx.doi.org/10.2147/ITT.S179656
_version_ 1783373106595758080
author Wang, Xu
Lu, Shuai
Xiao, Yankai
Xu, Ling
Zhou, Lingling
Hu, Junyan
Li, Bo
Zeng, Chengwu
Li, Yangqiu
author_facet Wang, Xu
Lu, Shuai
Xiao, Yankai
Xu, Ling
Zhou, Lingling
Hu, Junyan
Li, Bo
Zeng, Chengwu
Li, Yangqiu
author_sort Wang, Xu
collection PubMed
description BACKGROUND: T cell immunodeficiency is a common feature in patients with different kinds of hematological disease such as T cell non-Hodgkin lymphoma (T-NHL), B cells NHL (B-NHL), NK/T cell NHL (NK/T-CL) and acute myeloid leukemia (AML). In our recent research, we found that significantly lower expression levels in MALT1 and NF-κB were related to suppression of T cell activation. Therefore, this study was conducted to further investigate the role of downregulating MALT1 in the development of immunodeficiency in T cells. METHODS: We induced activation inhibition in CD3(+) T cells by MALT1 knockdown. Then we characterized the gene expression profile after MALT1 suppression by microarray analysis. RESULT: The differentially expressed genes were ZAP-70, p65, MDM2, ATM, NFATC2 which participate in the NF-κB, p53, and NFAT pathways in CD3(+) T cells after MALT1 downregulation. CONCLUSION: MALT1 suppression may contribute to immunodeficiency in T cells via suppression of T cell activation and proliferation pathways. These data may help to explain some of the characteristics of immunodeficiency of T cells.
format Online
Article
Text
id pubmed-6251356
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-62513562018-12-11 Alteration of gene expression profile in CD3(+) T-cells after downregulating MALT1 Wang, Xu Lu, Shuai Xiao, Yankai Xu, Ling Zhou, Lingling Hu, Junyan Li, Bo Zeng, Chengwu Li, Yangqiu Immunotargets Ther Original Research BACKGROUND: T cell immunodeficiency is a common feature in patients with different kinds of hematological disease such as T cell non-Hodgkin lymphoma (T-NHL), B cells NHL (B-NHL), NK/T cell NHL (NK/T-CL) and acute myeloid leukemia (AML). In our recent research, we found that significantly lower expression levels in MALT1 and NF-κB were related to suppression of T cell activation. Therefore, this study was conducted to further investigate the role of downregulating MALT1 in the development of immunodeficiency in T cells. METHODS: We induced activation inhibition in CD3(+) T cells by MALT1 knockdown. Then we characterized the gene expression profile after MALT1 suppression by microarray analysis. RESULT: The differentially expressed genes were ZAP-70, p65, MDM2, ATM, NFATC2 which participate in the NF-κB, p53, and NFAT pathways in CD3(+) T cells after MALT1 downregulation. CONCLUSION: MALT1 suppression may contribute to immunodeficiency in T cells via suppression of T cell activation and proliferation pathways. These data may help to explain some of the characteristics of immunodeficiency of T cells. Dove Medical Press 2018-11-20 /pmc/articles/PMC6251356/ /pubmed/30538965 http://dx.doi.org/10.2147/ITT.S179656 Text en © 2018 Wang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Wang, Xu
Lu, Shuai
Xiao, Yankai
Xu, Ling
Zhou, Lingling
Hu, Junyan
Li, Bo
Zeng, Chengwu
Li, Yangqiu
Alteration of gene expression profile in CD3(+) T-cells after downregulating MALT1
title Alteration of gene expression profile in CD3(+) T-cells after downregulating MALT1
title_full Alteration of gene expression profile in CD3(+) T-cells after downregulating MALT1
title_fullStr Alteration of gene expression profile in CD3(+) T-cells after downregulating MALT1
title_full_unstemmed Alteration of gene expression profile in CD3(+) T-cells after downregulating MALT1
title_short Alteration of gene expression profile in CD3(+) T-cells after downregulating MALT1
title_sort alteration of gene expression profile in cd3(+) t-cells after downregulating malt1
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251356/
https://www.ncbi.nlm.nih.gov/pubmed/30538965
http://dx.doi.org/10.2147/ITT.S179656
work_keys_str_mv AT wangxu alterationofgeneexpressionprofileincd3tcellsafterdownregulatingmalt1
AT lushuai alterationofgeneexpressionprofileincd3tcellsafterdownregulatingmalt1
AT xiaoyankai alterationofgeneexpressionprofileincd3tcellsafterdownregulatingmalt1
AT xuling alterationofgeneexpressionprofileincd3tcellsafterdownregulatingmalt1
AT zhoulingling alterationofgeneexpressionprofileincd3tcellsafterdownregulatingmalt1
AT hujunyan alterationofgeneexpressionprofileincd3tcellsafterdownregulatingmalt1
AT libo alterationofgeneexpressionprofileincd3tcellsafterdownregulatingmalt1
AT zengchengwu alterationofgeneexpressionprofileincd3tcellsafterdownregulatingmalt1
AT liyangqiu alterationofgeneexpressionprofileincd3tcellsafterdownregulatingmalt1